Global United States Direct-To-Consumer (DTC) Testing Market Overview:
Global United States Direct-To-Consumer (DTC) Testing Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global United States Direct-To-Consumer (DTC) Testing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of United States Direct-To-Consumer (DTC) Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the United States Direct-To-Consumer (DTC) Testing Market:
The United States Direct-To-Consumer (DTC) Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for United States Direct-To-Consumer (DTC) Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study United States Direct-To-Consumer (DTC) Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, United States Direct-To-Consumer (DTC) Testing market has been segmented into:
Ancestry Testing
Health Risk Assessment
Pharmacogenomics
By Application, United States Direct-To-Consumer (DTC) Testing market has been segmented into:
Nutritional Testing
Fitness and Exercise Testing
Metabolic Testing
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The United States Direct-To-Consumer (DTC) Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the United States Direct-To-Consumer (DTC) Testing market.
Top Key Players Covered in United States Direct-To-Consumer (DTC) Testing market are:
23andMe
Family Tree DNA
Ancestry
Genesis HealthCare
EasyDNA
Veritas
Myriad Genetics Inc.
Full Genomes Corporation
Inc
Living DNA Ltd.
Color Health
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: United States Direct-To-Consumer (DTC) Testing Market by Type
4.1 United States Direct-To-Consumer (DTC) Testing Market Snapshot and Growth Engine
4.2 United States Direct-To-Consumer (DTC) Testing Market Overview
4.3 Ancestry Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Ancestry Testing: Geographic Segmentation Analysis
4.4 Health Risk Assessment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Health Risk Assessment: Geographic Segmentation Analysis
4.5 Pharmacogenomics
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Pharmacogenomics: Geographic Segmentation Analysis
Chapter 5: United States Direct-To-Consumer (DTC) Testing Market by Application
5.1 United States Direct-To-Consumer (DTC) Testing Market Snapshot and Growth Engine
5.2 United States Direct-To-Consumer (DTC) Testing Market Overview
5.3 Nutritional Testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Nutritional Testing: Geographic Segmentation Analysis
5.4 Fitness and Exercise Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Fitness and Exercise Testing: Geographic Segmentation Analysis
5.5 Metabolic Testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Metabolic Testing: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 United States Direct-To-Consumer (DTC) Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 23ANDME
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 FAMILY TREE DNA
6.4 ANCESTRY
6.5 GENESIS HEALTHCARE
6.6 EASYDNA
6.7
6.8 VERITAS
6.9 MYRIAD GENETICS INC.
6.10 FULL GENOMES CORPORATION
6.11 INC
6.12 LIVING DNA LTD.
6.13 COLOR HEALTH
6.14 INC.
Chapter 7: Global United States Direct-To-Consumer (DTC) Testing Market By Region
7.1 Overview
7.2. North America United States Direct-To-Consumer (DTC) Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Ancestry Testing
7.2.4.2 Health Risk Assessment
7.2.4.3 Pharmacogenomics
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Nutritional Testing
7.2.5.2 Fitness and Exercise Testing
7.2.5.3 Metabolic Testing
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe United States Direct-To-Consumer (DTC) Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Ancestry Testing
7.3.4.2 Health Risk Assessment
7.3.4.3 Pharmacogenomics
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Nutritional Testing
7.3.5.2 Fitness and Exercise Testing
7.3.5.3 Metabolic Testing
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe United States Direct-To-Consumer (DTC) Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Ancestry Testing
7.4.4.2 Health Risk Assessment
7.4.4.3 Pharmacogenomics
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Nutritional Testing
7.4.5.2 Fitness and Exercise Testing
7.4.5.3 Metabolic Testing
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific United States Direct-To-Consumer (DTC) Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Ancestry Testing
7.5.4.2 Health Risk Assessment
7.5.4.3 Pharmacogenomics
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Nutritional Testing
7.5.5.2 Fitness and Exercise Testing
7.5.5.3 Metabolic Testing
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa United States Direct-To-Consumer (DTC) Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Ancestry Testing
7.6.4.2 Health Risk Assessment
7.6.4.3 Pharmacogenomics
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Nutritional Testing
7.6.5.2 Fitness and Exercise Testing
7.6.5.3 Metabolic Testing
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America United States Direct-To-Consumer (DTC) Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Ancestry Testing
7.7.4.2 Health Risk Assessment
7.7.4.3 Pharmacogenomics
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Nutritional Testing
7.7.5.2 Fitness and Exercise Testing
7.7.5.3 Metabolic Testing
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
United States Direct-To-Consumer (DTC) Testing Scope:
|
Report Data
|
United States Direct-To-Consumer (DTC) Testing Market
|
|
United States Direct-To-Consumer (DTC) Testing Market Size in 2025
|
USD XX million
|
|
United States Direct-To-Consumer (DTC) Testing CAGR 2025 - 2032
|
XX%
|
|
United States Direct-To-Consumer (DTC) Testing Base Year
|
2024
|
|
United States Direct-To-Consumer (DTC) Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
23andMe, Family Tree DNA, Ancestry, Genesis HealthCare, EasyDNA,, Veritas, Myriad Genetics Inc., Full Genomes Corporation, Inc, Living DNA Ltd., Color Health, Inc..
|
|
Key Segments
|
By Type
Ancestry Testing
Health Risk Assessment
Pharmacogenomics
By Applications
Nutritional Testing
Fitness and Exercise Testing
Metabolic Testing
|
